Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

ClinicalTrials.gov ID: NCT00863707

Public ClinicalTrials.gov record NCT00863707. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multicenter, Double-Blind, Randomized, Placebo-controlled Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Study identification

NCT ID
NCT00863707
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
511 participants

Conditions and interventions

Interventions

  • Regadenoson Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009
Primary completion
Nov 30, 2009
Completion
Nov 30, 2009
Last update posted
May 17, 2012

2009

United States locations

U.S. sites
41
U.S. states
19
U.S. cities
39
Facility City State ZIP Site status
Not listed Anniston Alabama 36207
Not listed Little Rock Arkansas 72204
Not listed Bell Gardens California 90202
Not listed Fullerton California 92835
Not listed Garden Grove California 92845
Not listed Los Angeles California 90017
Not listed Los Angeles California 90022
Not listed Mission Viejo California 92691
Not listed Oakland California 94609
Not listed Roseville California 95661
Not listed Santa Ana California 92704
Not listed Newark Delaware 19713
Not listed Wilmington Delaware 19808
Not listed Fort Lauderdale Florida 33308
Not listed Miami Florida 33173
Not listed Orlando Florida 32809
Not listed Trinity Florida 34655
Not listed Winter Park Florida 32789
Not listed Ellijay Georgia 38540
Not listed Chicago Illinois 60616
Not listed Auburn Maine 04210
Not listed Detroit Michigan 48202
Not listed Flint Michigan 48504
Not listed Minneapolis Minnesota 55415
Not listed Ridgewood New Jersey 07450
Not listed Somerset New Jersey 08873
Not listed New York New York 10010
Not listed Springfield Gardens New York 11413
Not listed Springfield Ohio 45505
Not listed Oklahoma City Oklahoma 73103
Not listed Bend Oregon 97701
Not listed Duncansville Pennsylvania 16635
Not listed Indiana Pennsylvania 15701
Not listed Tyrone Pennsylvania 16686
Not listed Wyomissing Pennsylvania 19610
Not listed Charleston South Carolina 29425
Not listed Spartanburg South Carolina 29303
Not listed Knoxville Tennessee 37920
Not listed Houston Texas 77055
Not listed Houston Texas 77074
Not listed Sugar Grove Texas 77478

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00863707, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2012 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00863707 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →